Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed (confirmed by a tissue sample/biopsy) with a type of blood cancer involving mature T-cells or NK-cells that has either never been treated, has come back after treatment, or has stopped responding to treatment.
- Most subtypes of a group of cancers called peripheral T-cell lymphoma (PTCL) are eligible — if you are unsure whether your specific subtype qualifies, confirm with the trial site.
Who may not be able to join:
- People diagnosed with certain specific types of T-cell or NK-cell cancers, including: T-cell large granular lymphocytic leukemia, skin-based T-cell lymphomas such as mycosis fungoides (including transformed versions), Sézary syndrome, primary cutaneous CD30+ disorders, or early/precursor forms of T/NK-cell cancers.
- Adults who are not able to give their own consent to participate.
- People who are under 18 years of age, including infants, children, and teenagers.
- Women who are currently pregnant.
- People who are currently imprisoned.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 650-224-0183
Australian sites
+61 8 7074 0000
+03-8559-5000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Overall Survival; Progression-free Survival; Duration of Response; Time to progression; Number of subjects proceeding to stem cell transplantation; Association of tumor specific somatic variants with treatment response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.